182 related articles for article (PubMed ID: 22907864)
1. Angiogenesis and lymphangiogenesis in early-stage laryngeal carcinoma: Prognostic implications.
Bolzoni Villaret A; Barbieri D; Peretti G; Schreiber A; Fisogni S; Lonardi S; Facchetti F; Nicolai P
Head Neck; 2013 Aug; 35(8):1132-7. PubMed ID: 22907864
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications.
Bolzoni Villaret A; Schreiber A; Facchetti F; Fisogni S; Lonardi S; Lombardi D; Cocco D; Redaelli de Zinis LO; Nicolai P
Head Neck; 2010 Jun; 32(6):786-92. PubMed ID: 19890908
[TBL] [Abstract][Full Text] [Related]
3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
4. [Association between lymphangiogenesis and clinicopathological features and prognosis in laryngeal carcinoma].
Zou JD; Fu HY; Xu W; Lü ZH; Cao HY; Luan XY
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):461-4. PubMed ID: 21875489
[TBL] [Abstract][Full Text] [Related]
5. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
6. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
7. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
Cho EI; Kowalski DP; Sasaki CT; Haffty BG
Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
[TBL] [Abstract][Full Text] [Related]
8. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
9. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
12. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
Schlüter A; Weller P; Kanaan O; Nel I; Heusgen L; Höing B; Haßkamp P; Zander S; Mandapathil M; Dominas N; Arnolds J; Stuck BA; Lang S; Bankfalvi A; Brandau S
BMC Cancer; 2018 Mar; 18(1):272. PubMed ID: 29523110
[TBL] [Abstract][Full Text] [Related]
13. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
Lin JY; Li XY; Dong P; Nakashima T
J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
[TBL] [Abstract][Full Text] [Related]
15. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients.
Garcia-Carracedo D; Rodrigo JP; Astudillo A; Nieto CS; Gonzalez MV
BMC Cancer; 2010 Aug; 10():416. PubMed ID: 20698954
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma.
Baek SK; Jung KY; Lee SH; Woo JS; Kwon SY; Chung EJ; Kim TH; Chae YS
Laryngoscope; 2009 Jul; 119(7):1325-30. PubMed ID: 19444880
[TBL] [Abstract][Full Text] [Related]
18. [Laryngeal cancer and angiogenesis].
Beatrice F; Valente G; Cammarota R; Bisciari T; Ragona R; Giusti U; Bussolino F; Sartoris A
Acta Otorhinolaryngol Ital; 1996 Aug; 16(4):355-62. PubMed ID: 9082830
[TBL] [Abstract][Full Text] [Related]
19. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
20. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]